Monte Financial Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,383
Closed -$369K 74
2019
Q4
$369K Sell
2,383
-551
-19% -$79.4K 0.27% 59
2019
Q3
$396K Sell
2,934
-851
-22% -$111K 0.32% 58
2019
Q2
$462K Buy
3,785
+128
+4% +$14.2K 0.39% 51
2019
Q1
$380K Sell
3,657
-219
-6% -$22.6K 0.33% 51
2018
Q4
$441K Sell
3,876
-68
-2% -$7.29K 0.47% 40
2018
Q3
$455K Sell
3,944
-49
-1% -$5.37K 0.43% 43
2018
Q2
$414K Sell
3,993
-487
-11% -$49.3K 0.42% 43
2018
Q1
$441K Sell
4,480
-133
-3% -$12.6K 0.46% 42
2017
Q4
$391K Buy
+4,613
New +$381K 0.4% 44

Other funds holding RMD

Monte Financial Group's RMD Position: Q1 2020 in Review

Monte Financial Group sold out of ResMed (RMD) in Q1 2020, closing a stake of 2,383 shares — an estimated $369K sold.

Monte Financial Group first reported a position in RMD in Q4 2017 and held it in 9 quarters. The position peaked at $462K in Q2 2019. 584 funds tracked by Wall St. Rank hold RMD as of Q1 2020.

  • Monte Financial Group reported no remaining ResMed position as of Q1 2020 after selling out during the quarter.
  • Monte Financial Group sold 2,383 ResMed shares in Q1 2020, an estimated $369K.
  • Monte Financial Group first reported a position in ResMed in Q4 2017 and held it in 9 quarters.
  • Monte Financial Group's ResMed position peaked at $462K in Q2 2019.
  • 584 funds tracked by Wall St. Rank held ResMed as of Q1 2020.

Based on Monte Financial Group's 13F filing for Q1 2020, filed 28 Apr 2020.